Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV10 vs PCV13 in Papua New Guinean children
NCT01619462Phase 3Unknown
- Sponsor
- Papua New Guinea Institute of Medical Research
- Start
- Nov 2011
- Primary completion
- Apr 2014
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of 10-valent pneumococcal conjugate vaccine, pneumococcal 13-valent conjugate vaccine in pneumonia, meningitis, Bacteremia, sepsis, otitis media, sponsored by Papua New Guinea Institute of Medical Research. Status: unknown.
02
Drugs
10-valent pneumococcal conjugate vaccinepneumococcal 13-valent conjugate vaccine
03
Conditions
pneumoniameningitisBacteremiasepsisotitis media
Beyond the preview
Go deeper on NCT01619462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01619462.